Blog
RSS FeedPosted by Michael Wonder on 22 Jun 2022
New $11 million winter vaccine communication campaign and availability of antivirals
22 June 2022 - The Australian Government today launched an $11 million six-week campaign to encourage people to get vaccinated for ...
Posted by Michael Wonder on 20 Jun 2022
HIRA reviews reimbursing antidiabetic combo therapies
15 June 2022 - HIRA has been analysing how new reimbursements for anti-diabetic combination therapies mixing oral SGLT-2 and DPP-4 ...
Posted by Michael Wonder on 20 Jun 2022
PHARMAC's latest breast cancer drug funding 'way short' - advocate
16 June 2022 - On Wednesday PHARMAC announced $190 million to fund cancer treatments and other medicines. ...
Posted by Michael Wonder on 16 Jun 2022
NHS lands breakthrough in global battle against superbugs
15 June 2022 - The NHS is set to roll out two ‘superbug’ busting drugs through a world first, pioneering ...
Posted by Michael Wonder on 16 Jun 2022
New PHARMAC funded cancer drugs already 'old and cheap', patient advocate Malcolm Mulholland says
16 June 2022 - New cancer drugs that will now be funded by the Government drug buying agency are already ...
Posted by Michael Wonder on 15 Jun 2022
EFPIA-EURORDIS joint statement on patient access to medicines for rare diseases
15 June 2022 - Today marks the publication of the EFPIA-EURORDIS joint statement on patient access to medicines for rare diseases. ...
Posted by Michael Wonder on 15 Jun 2022
PHARMAC widens access to safe sex drug after 'overwhelming support'
15 June 2022 - PHARMAC is overhauling its criteria for prescriptions to an effective safe sex drug common to gay men. ...
Posted by Michael Wonder on 15 Jun 2022
Calls for 'blockbuster' osteoporosis drug to be made widely available
14 June 2022 - Experts want to see a new "blockbuster" drug made accessible for more patients suffering from osteoporosis. ...
Posted by Michael Wonder on 15 Jun 2022
PHARMAC announces first round of medicine funding decisions following $191 million pharmaceutical budget increase
15 June 2022 - PHARMAC today announces the first round of changes to medicines funding following its $191 million pharmaceutical ...
Posted by Michael Wonder on 14 Jun 2022
PHARMAC seeks views on access criteria for COVID-19 treatments
14 June 2022 - PHARMAC is seeking feedback on access criteria for two new COVID-19 treatments – tixagevimab with cilgavimab ...
Posted by Michael Wonder on 09 Jun 2022
The days of the independent republic of PHARMAC are far from over
9 June 2022 - When he announced the government’s response to the recent independent review of PHARMAC Health Minister Andrew Little ...
Posted by Michael Wonder on 08 Jun 2022
TLV reconsiders subsidy of cyclin-dependent kinase 4/6 inhibitor Verzenios
8 June 2022 - Since April 2022, Verzenios has had market approval for the treatment of adult patients with early breast ...
Posted by Michael Wonder on 08 Jun 2022
Irish parents ‘breaking down and crying’ as children denied life changing cystic fibrosis medication
8 June 2022 - Sarah O’Keeffe found out that her son would not be getting the medication that would improve his ...
Posted by Michael Wonder on 07 Jun 2022
Response to engagement on proposals for the Innovative Medicines Fund
7 June 2022 - NHS England and NICE asked for comments on our proposals for the Innovative Medicines Fund. ...
Posted by Michael Wonder on 07 Jun 2022
Patients to have earlier access to cutting edge treatments on NHS
7 June 2022 - The most promising medicines will be fast-tracked to NHS patients through Innovative Medicines Fund ...